DNA PATERNITY & RELATIONSHIP TESTING
DNA Paternity & Relationship Testing including Immigration and Non-Invasive Prenatal (while pregnant – as early as 7 weeks) is performed through
our affiliation with a full service AABB (American Association of Blood Banks) and NYS Department of Health (DOH) accredited laboratory.
All DNA test results are valid in any court in the U.S. and with the U.S. Department of Homeland Security (U.S. Citizenship and Immigration Services – USCIS).
Immigration Testing sites available virtually anywhere in the world including Egypt, Yemen, Djibouti, Afghanistan, Africa, Jamaica, Haiti, and many more.
DRUG, ALCOHOL & FORENSIC TESTING
Extensive experience and knowledge in the field of drug, alcohol and forensic testing for substances of abuse via urine and hair follicle.
Full-service drug and alcohol testing for businesses / employers, private individuals, court ordered, and probation. Offering DOT and non-DOT testing including EtG (Ethyl Glucuronide), Opiates, Fentanyl, Anabolic Steroids screen, Synthetic Cannabinoids (K2, Spice) and customized drug panels.
FORMFOX, LABCORP, QUEST, MEDTOX, CRL, OMEGA, PSYCHEMEDICS and other laboratory collections performed.
As monitors for CPH (Committee for Physician Health – a division of the Medical Society of the State of New York)
we manage observed random urine drug testing for program participants (physicians, residents, medical students and physician assistants).
We can also monitor pharmacists and nurses that require random testing.
BACKGROUND CHECKS / EMPLOYEE SCREENING
Background check services designed to facilitate informed hiring decisions, less employee turnover, and reduced company risk to litigation.
Choose from background check packages that will assist in verifying / assessing a potential employee’s background.
COVID-19 IgG / IgM Rapid 10 Minute Test
On March 16th, the U.S. government took an unprecedented step towards access to Coronavirus Disease (COVID-19) testing by allowing developers of certain tests to commercialize the products in the U.S. without the requirement for an FDA approval or Emergency Use Authorization (EUA). https://www.fda.gov/media/135659/download
As a result, the COVID-19 IgG and IgM Rapid Test is being distributed in compliance with the above FDA regulation. This qualitative serology test is designed to detect the antibodies (specific proteins) that develop in the body following exposure to COVID-19. IgM antibodies are typically released in the early stages of an infection. IgG antibodies are typically the body’s longer-term response to an infection. Researchers are trying to determine how quickly the body produces these COVID-19 antibodies and current estimates are that the IgM antibodies might be released within approximately the first week after infection. Symptoms of COVID-19 are generally appearing 1-14 days following viral exposure.
The U.S. has struggled to test for this virus at scale. This is related to the limited availability of molecular polymerase chain reaction (PCR) tests that require samples to be sent to a laboratory and, therefore, may take days to get results back. The speed of this new 10 minute rapid test allows decision makers to be more responsive in proactively decreasing the spread of the Coronavirus. Test results may be helpful in determining who should be self-quarantined. This test is to be used only for pre-screening purposes.
In an effort to assist our communities in pre-screening those with potential Coronavirus symptoms, we are offering this COVID-19 IgG and IgM 10-minute Rapid Test. The test procedure involves a simple fingerstick which according to preliminary research yields a high sensitivity, high specificity result. Once ordered, we will deliver an easy to administer kit which will include everything you need to perform the test on site – including a package insert/procedure guide and a comprehensive video.
We want to make our partners aware that this test is not meant to replace PCR testing. Because the PCR test detects the RNA (genetic material) of the virus, it remains the most accurate testing available.
Access to this rapid COVID-19 test will allow employers/facilities to:
• test persons with potential coronavirus symptoms before they have access to those they work with or take care of
• encourage tested persons to alert their medical/healthcare providers early so they can obtain PCR diagnostic testing
• encourage tested persons to self-quarantine early to decrease the rate of spread of the Coronavirus
MEDICAL – LEGAL CONSULTING
Medical Legal Nurse Consulting services since 1990 for the legal (plaintiff / defense) community, insurance companies and corporations.
Specializing in reviewing and analyzing medical malpractice, wrongful death, personal injury and criminal law cases.
Extensive experience reviewing, analyzing, interpreting and summarizing medical records and other pertinent documents.
Skilled in locating and providing medical experts for legal cases.